CRSP- Crispr Therapeutics AG

Name: Crispr Therapeutics AG Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Crispr Therapeutics AG (CRSP) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kulkarni Samarth	255.5K	$13.39M	-
Dir	George Simeon	238.9K	$12.52M	-
Other	Kasinger James R.	94.3K	$4.94M	-
Other	Patel Naimish	38.5K	$2.02M	-
Dir	Treco Douglas A	22.0K	$1.15M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 23, 2026	Prasad Raju53	Chief Financial Officer	Sale+OE	3,708	$46.78	$173,460.24	-19.2%	-	-
Mar 23, 2026	Kulkarni Samarth69	Chief Executive Officer	Sale+OE	10,020	$46.78	$468,735.60	-3.8%	-	-
Mar 23, 2026	Kasinger James R.64	General Counsel And Secretary	Sale+OE	3,182	$46.78	$148,853.96	-3.3%	-	-
Mar 16, 2026	Kulkarni Samarth69	Chief Executive Officer	Sale+OE	10,349	$48.26	$499,442.74	-4.0%	-	-
Mar 16, 2026	Kasinger James R.64	General Counsel And Secretary	Sale+OE	3,450	$48.26	$166,497.00	-3.6%	-	-
Mar 16, 2026	Prasad Raju53	Chief Financial Officer	Sale+OE	9,869	$48.26	$476,277.94	-23.8%	-	-
Mar 16, 2026	Patel Naimish	Chief Medical Officer	Sale+OE	3,150	$48.26	$152,019.00	-19.3%	-	-
Mar 11, 2026	Kulkarni Samarth69	Chief Executive Officer	Sale+OE	9,798	$52.80	$517,334.40	-4.0%	-	-
Mar 11, 2026	Kasinger James R.64	General Counsel And Secretary	Sale+OE	2,800	$52.80	$147,840.00	-3.1%	-	-
Jan 6, 2026	Prasad Raju53	Chief Financial Officer	Sale+OE	29,700	$60.16	$1,786,635.87	-44.6%	-15.5%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC